These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2184824)

  • 1. [Pancreatic enzyme substitution in patients with mucoviscidosis].
    Henker J
    Gastroenterol J; 1990; 49(4):151-5. PubMed ID: 2184824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
    Henker J; Hoffmann D; Paul D; Hein J; Paditz E
    Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
    Freise J; Horstkotte H
    Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.
    Walkowiak J; Lisowska A
    J Pediatr; 2005 Dec; 147(6):870-1. PubMed ID: 16356455
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pancreatic enzyme replacement in mucoviscidosis (CF): clinical evaluation of a gastric acid-resistant pancreatin preparation in encapsulated microtablet form].
    Stern M; Plettner C; Grüttner R
    Klin Padiatr; 1988; 200(1):36-9. PubMed ID: 2452915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic extract therapy in exocrine pancreatic insufficiency].
    Santini B; Ivaldi AP
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):133-7. PubMed ID: 8286485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment.
    Bruno MJ; Haverkort EB; Tytgat GN; van Leeuwen DJ
    Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional management of cystic fibrosis patients.
    Kalnins D; Durie PR; Pencharz P
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):348-54. PubMed ID: 17414506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
    Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
    Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.